Recent News

• 04.08.2025 - iCAD Expands Executive Leadership with Appointment of Mark Koeniguer as Chief Commercial Officer
• 03.19.2025 - iCAD Reports Financial Results for Fourth Quarter and Fiscal Year Ended December 31, 2024
• 03.12.2025 - iCAD Leadership in Breast Health AI Showcased at ECR 2025
• 03.11.2025 - iCAD to Report Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025
• 03.05.2025 - iCAD and RamSoft Announce Partnership to Deliver ProFound® AI-Powered Mammography Solutions Across North America
• 02.26.2025 - Koios Medical and iCAD Partner to Expand AI-Powered, Multi-Modality Breast Cancer Detection Solutions at ECR 2025
• 02.19.2025 - iCAD To Showcase Five AI-Powered Research Presentations Advancing Breast Cancer Detection, Risk Evaluation, and Breast Arterial Calcification Assessment at ECR 2025
• 01.27.2025 - iCAD Pre-Announces Estimated Q4 2024 Revenue

Recent Filings

• 03.31.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.19.2025 - EX-99.1 EX-99.1
• 03.19.2025 - 8-K Current report
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.27.2025 - EX-99.1 EX-99.1